Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of N
about
Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control studyThe Risk of Specific Congenital Anomalies in Relation to Newer Antiepileptic Drugs: A Literature ReviewManagement of epilepsy during pregnancy: an updateNeurodevelopmental effects of fetal antiepileptic drug exposureExposure to folic acid antagonists during the first trimester of pregnancy and the risk of major malformations.Rational Polytherapy with Antiepileptic Drugs.Affect of seizures during gestation on pregnancy outcomes in women with epilepsyComparative safety of anti-epileptic drugs among infants and children exposed in utero or during breastfeeding: protocol for a systematic review and network meta-analysis.Long-term consequences after exposure to antiepileptic drugs in utero.New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety?Topiramate, zonisamide and small for gestational age: maternal factors, timing of exposure and baby fatGenetic and maternal effects on valproic acid teratogenesis in C57BL/6J and DBA/2J mice.Prevalence of treated epilepsy in Korea based on national health insurance dataTeratogenic effects of antiepileptic drugsAdvances in epilepsy: new perspectives on new-onset epilepsy, comorbidities, and pharmacotherapy.Bicuspid aortic valve and severe aortic stenosis in a newborn exposed to carbamazapine during pregnancy.Relationship of child IQ to parental IQ and education in children with fetal antiepileptic drug exposure.IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort studyClinical therapeutics in pregnancy.Drug use and/or exposure in pregnancy: Presence of risk versus quantity of risk.The need for safer medication use in pregnancy.Epileptogenesis: can the science of epigenetics give us answers?Recommendations for the treatment of epilepsy in adult patients in general practice in Belgium: an update.Comparative teratogenicity analysis of valnoctamide, risperidone, and olanzapine in mice.Developmental effects of antiepileptic drugs and the need for improved regulations.Pharmacokinetics of drugs in pregnancy.Do lamotrigine and levetiracetam solve the problem of using sodium valproate in women with epilepsy?Prenatal exposure to carbamazepine reduces hippocampal and cortical neuronal cell population in new-born and young mice without detectable effects on learning and memory.Prenatal exposure to antiepileptic drugs and use of primary healthcare during childhood: a population-based cohort study in Denmark.AED discontinuation may not be dangerous in seizure-free patients.Safety aspects of antiepileptic drugs--focus on pharmacovigilance.Neurobehavioral consequences of prenatal antiepileptic drug exposure.Adverse drug reactions to gabapentin and pregabalin: a review of the French pharmacovigilance database.The long-term safety of antiepileptic drugs.Management of adverse effects of mood stabilizers.Fetal Growth and Premature Delivery in Pregnant Women on Anti-epileptic Drugs.Management of women with epilepsy: from preconception to post-partum.Use of Antiepileptic Drugs During Pregnancy: Evolving Concepts.Birth outcomes after prenatal exposure to antiepileptic drugs--a population-based study.Duloxetine withdrawal syndrome in a newborn.
P2860
Q24631492-DD4A42E7-A820-447C-A295-917FE5CC700CQ26741366-C4EF789B-D5F3-40B1-902D-6CB5B89971DAQ26752470-5D57B10A-F761-4A84-A376-712E917325ECQ28080703-0065293E-C764-49F9-9999-79FFBD72CEEEQ33608040-C41EDC36-F3D7-4F4B-A545-C712EFDC4A02Q33664046-21DA79AB-C735-4EF1-940B-9CFC1BD12C6EQ33719064-27A3E4DC-E8D7-44B6-94EC-F94E029F6773Q33861432-E92E3D25-AFF6-4194-99DA-AC75B6EB43CDQ33949257-429DC270-18E2-4446-9BE8-290882CA8D52Q33949491-DA5A71F4-A41D-4460-8F34-F8AC0A5082F9Q33996234-2CCA0EFC-1E57-4212-A7B8-235BD14D25E8Q34000795-C5AB59D5-5C06-4BCF-A888-1E8879F03C7DQ34179734-627C3F4C-CAAB-4D47-9F59-8BD5A734C151Q34267151-3F921274-1951-43D3-96D1-6185EF75BC67Q34343400-10EAF5CD-5528-41AA-ACEA-D95D36737533Q34843195-735F9F64-02B3-427B-8EBB-6CA1023B8B06Q35042877-298B3C04-EF92-4D03-B092-B02AE8304013Q35106308-EB4BC77C-CC63-42EE-9DE7-39A100050BA6Q35113890-983480B7-CC06-4A3E-AD4C-23E0C76D52DFQ35686948-D8BF0966-F59A-4556-AC47-E1D2B70533C2Q35926283-0CADBA35-B978-4E38-9EBD-2C0FA2D284EEQ36008878-1DEFD118-349A-4158-9BF0-4A3B2B5B96B7Q36031424-4A865321-DB2A-4026-B5C3-9944E13EF877Q36244649-F086995B-23F4-4BE3-B2F5-CD08266CA47AQ36521267-35ADEAF9-2A7A-455A-9638-A69FC72FE989Q36734138-29652D9F-4890-43C5-81D0-A5EC5B41BEECQ37186130-5E19DA57-5BAC-49CE-9CD8-E8AA2BD48AF9Q37309361-ECDC88BC-414E-4049-B40F-85B38A216A5BQ37576850-39B8C5A5-6C19-46DE-8A98-73B1E22B9420Q37821330-F54ABEF4-ACC3-41F1-9808-6F2D5965F6B1Q37954227-A444ED9F-943A-4458-9E61-F1E70D1C2C51Q37980247-F9F665E1-0EC1-494A-8EE3-F54878A549A4Q38073712-7689EA76-6B8F-4BED-AE54-B9DA82B5AB41Q38106856-4EBD1346-0948-44A1-8E25-418B0A1F2299Q38530476-273483B3-C43A-42FE-9EEF-F5FA9454D4B5Q38600924-107CCC42-628E-45CB-BF75-E354FEA2828FQ38655275-B250193C-BEFB-4481-9A80-97F220985297Q39510801-3EFEE562-618A-474F-B045-C0DEB7B57449Q43447747-FA311EEE-D081-40D0-89B8-7D45B408F96FQ43921724-9A59714C-9F68-45C7-ACB8-B92084E698BD
P2860
Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of N
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Management issues for women wi ...... e of the American Academy of N
@en
Management issues for women with epilepsy-Focus on pregnancy
@nl
type
label
Management issues for women wi ...... e of the American Academy of N
@en
Management issues for women with epilepsy-Focus on pregnancy
@nl
prefLabel
Management issues for women wi ...... e of the American Academy of N
@en
Management issues for women with epilepsy-Focus on pregnancy
@nl
P2093
P50
P1433
P1476
Management issues for women wi ...... e of the American Academy of N
@en
P2093
Allan Krumholz
American Academy of Neurology
American Epilepsy Society
Andrew N Wilner
Barbara S Koppel
Barry Gidal
Blanca Vazquez
Collin A Hovinga
Cynthia L Harden
Deborah Hirtz
P2860
P304
P356
10.1111/J.1528-1167.2009.02129.X
P577
2009-05-01T00:00:00Z